| Absorption |
| Blood-Brain Barrier | BBB- | 0.7737 |
| Human Intestinal Absorption | HIA- | 0.7542 |
| Caco-2 Permeability | Caco2- | 0.7529 |
| P-glycoprotein Substrate | Substrate | 0.7491 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9315 |
| Non-inhibitor | 0.9870 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8588 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6208 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7548 |
| CYP450 2D6 Substrate | Non-substrate | 0.7591 |
| CYP450 3A4 Substrate | Non-substrate | 0.6421 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8980 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8581 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9067 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7789 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8286 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9754 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9017 |
| Non-inhibitor | 0.7050 |
| AMES Toxicity | Non AMES toxic | 0.7122 |
| Carcinogens | Non-carcinogens | 0.8601 |
| Fish Toxicity | High FHMT | 0.7162 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9629 |
| Honey Bee Toxicity | Low HBT | 0.8583 |
| Biodegradation | Not ready biodegradable | 0.8795 |
| Acute Oral Toxicity | III | 0.6749 |
| Carcinogenicity (Three-class) | Non-required | 0.6161 |